Martin Pomper

Professor and Chair of Radiology

University of Texas Southwestern Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Imaging Medical Imaging professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Martin Pomper is a Professor and Chair of Radiology at The University of Texas Southwestern Medical Center. His research focuses on the detection and treatment of prostate cancer, with recent articles addressing biochemically recurrent prostate cancer, PSMA-targeted imaging, and new therapeutic agents. He is also involved in innovative methodologies in radionuclide imaging and oncologic applications. Based in the United States, he contributes significantly to the field of radiology and nuclear medicine.

Articles (9)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (3)

Wenyi Shao

Johns Hopkins University

UNITED STATES

View details

Hyun Woo Chung

Konkuk University Medical Center

SOUTH KOREA

View details

Jingyan Xu

Johns Hopkins University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Martin Pomper

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Detection of Biochemically Recurrent Prostate Cancer with [<sup>18</sup>F]DCFPyL PET/CT: An Updated Systematic Review and Meta-Analysis with a Focus on Correlations with Serum Prostate-Specific Antigen Parameters

Preclinical Evaluation of a New Series of Albumin-Binding <sup>177</sup>Lu-Labeled PSMA-Based Low-Molecular-Weight Radiotherapeutics

Association of True Positivity with Serum Prostate-Specific Antigen Levels and Other Clinical Factors in Indeterminate PSMA-RADS-3A Lesions Identified on 18F-DCFPyL PET/CT Scans

Generation of Digital Brain Phantom for Machine Learning Application of Dopamine Transporter Radionuclide Imaging

A Series of PSMA-Targeted Near-Infrared Fluorescent Imaging Agents

An Evaluation of CXCR4 Targeting with PAMAM Dendrimer Conjugates for Oncologic Applications

A Unique Core–Shell Structured, Glycol Chitosan-Based Nanoparticle Achieves Cancer-Selective Gene Delivery with Reduced Off-Target Effects

Hematotoxicity and Nephrotoxicity in Prostate Cancer Patients Undergoing Radioligand Therapy with [<sup>177</sup>Lu]Lu-PSMA I&T

Whole-Body [<sup>18</sup>F]FDG PET/CT Can Alter Diagnosis in Patients with Suspected Rheumatic Disease

Collaborators (3)

Wenyi Shao

Hyun Woo Chung

Jingyan Xu

Make your next move.

Martin Pomper

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Detection of Biochemically Recurrent Prostate Cancer with [<sup>18</sup>F]DCFPyL PET/CT: An Updated Systematic Review and Meta-Analysis with a Focus on Correlations with Serum Prostate-Specific Antigen Parameters

Preclinical Evaluation of a New Series of Albumin-Binding <sup>177</sup>Lu-Labeled PSMA-Based Low-Molecular-Weight Radiotherapeutics

Association of True Positivity with Serum Prostate-Specific Antigen Levels and Other Clinical Factors in Indeterminate PSMA-RADS-3A Lesions Identified on 18F-DCFPyL PET/CT Scans

Generation of Digital Brain Phantom for Machine Learning Application of Dopamine Transporter Radionuclide Imaging

A Series of PSMA-Targeted Near-Infrared Fluorescent Imaging Agents

An Evaluation of CXCR4 Targeting with PAMAM Dendrimer Conjugates for Oncologic Applications

A Unique Core&ndash;Shell Structured, Glycol Chitosan-Based Nanoparticle Achieves Cancer-Selective Gene Delivery with Reduced Off-Target Effects

Hematotoxicity and Nephrotoxicity in Prostate Cancer Patients Undergoing Radioligand Therapy with [<sup>177</sup>Lu]Lu-PSMA I&amp;T

Whole-Body [<sup>18</sup>F]FDG PET/CT Can Alter Diagnosis in Patients with Suspected Rheumatic Disease

Collaborators (3)

Wenyi Shao

Hyun Woo Chung

Jingyan Xu

Make your next move.

A Unique Core–Shell Structured, Glycol Chitosan-Based Nanoparticle Achieves Cancer-Selective Gene Delivery with Reduced Off-Target Effects

Hematotoxicity and Nephrotoxicity in Prostate Cancer Patients Undergoing Radioligand Therapy with [<sup>177</sup>Lu]Lu-PSMA I&T